GW Pharma's Guy sells to Whittle

Geoffrey Guy, executive chairman of GW Pharmaceuticals, has sold almost £600,000 of shares in the cannabis-based medicine firm to co-founder Brian Whittle.

The purchase of 750,000 shares from Guy at 79p each cost Whittle, who retired as a director at GW last year, £592,500.

MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Guy also gifted, for nil consideration, a further 782,111 shares to Whittle and members of Whittle's family.

Despite transferring over 1.5m shares, or 1.3% of the business, Guy still owns a 15.2% stake.

GW posted a maiden annual profit last month. It made £4m on revenue up to £16.1m from £5.7m thanks to increased sales and milestone revenue from Almirall and Sativax

Top Director Buys

Value: £129,366

Value: £53,480

Value: £35,340

Value: £24,878

Value: £22,825

Value: £19,902

Value: £11,750

Value: £11,600

Value: £10,536

Top Director Sells

Value: £592,500

Explore More

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.